The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Rivaroxaban

Australian Public Assessment Report

AusPAR

AusPAR: Rivaroxaban [PDF, 614.54 KB]

AusPAR: Rivaroxaban [Word, 689.88 KB]

Attachment: Product Information: Rivaroxaban [PDF, 367.14 KB]

Attachment: Product Information: Rivaroxaban [Word, 147.59 KB]

Attachment: Extract from Clinical Evaluation Report: Rivaroxaban [PDF, 827.73 KB]

Attachment: Extract from Clinical Evaluation Report: Rivaroxaban [Word, 1.15 MB]

Device/Product Name

Xarelto

Active ingredients

Rivaroxaban

AusPAR Date

2 October 2013

Published

29 October 2013

Submission Number

PM-2012-01179-3-3

Submission Type

Extension of indications

Decision

Approved